采用治疗中需处理的不良反应症状量表(TESS)评定安全性。
Treatment emergent symptoms scale (TESS) was used to evaluate the safety.
采用阳性与阴性症状量表（PANSS）评定疗效，副反应量表（TESS）评定不良反应。
Positive and Negative Syndrome Scale (PANSS) was used to assess the efficacy, side effects scale (TESS) was used to assess adverse reactions.
采用阳性症状量表和阴性症状量表(PANSS)以评定齐拉西酮对女性精神分裂症的疗效，采用不良反应量表(TESS)评定该药物的副反应。
The positive and negative symptom scale (PANSS) is adopted to appraise the curative effect, and the treatment emergent symptom scale (TESS) is adopted to appraise by-reaction.
以阳性和阴性症状量表（PANSS）评定临床疗效，以副反应量表（TESS）评定不良反应。
The efficacy was evaluated by positive and negative symptom scale(PANSS), and the side effects by treatment emergent symptom scale(TESS).
用阳性与阴性症状量表(PANSS)和副反应量表(TESS)评定疗效和不良反应。
Positive and negative symptom scale (PANSS) and treatment emergent symptom scale (TESS) were used to evaluate the efficacy and side effects respectively.
用阳性与阴性症状量表(PANSS)和副反应量表(TESS)评定疗效和不良反应。
PANSS and TESS were used to assess the clinic and side effects.
用阳性与阴性症状量表(PANSS)和副反应量表(TESS)评定疗效和不良反应。
PANSS and TESS were used to assess the clinic and side effects.
应用推荐